[go: up one dir, main page]

AR080908A1 - FORMULATIONS OF A PIRIDAZIN-BIPIRAZINIL - Google Patents

FORMULATIONS OF A PIRIDAZIN-BIPIRAZINIL

Info

Publication number
AR080908A1
AR080908A1 ARP110101288A ARP110101288A AR080908A1 AR 080908 A1 AR080908 A1 AR 080908A1 AR P110101288 A ARP110101288 A AR P110101288A AR P110101288 A ARP110101288 A AR P110101288A AR 080908 A1 AR080908 A1 AR 080908A1
Authority
AR
Argentina
Prior art keywords
bipirazinil
piridazin
formulations
bipirazinyl
dimetii
Prior art date
Application number
ARP110101288A
Other languages
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR080908A1 publication Critical patent/AR080908A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una formulacion farmacéutica de 2-[(R)-4-(6-bencil-4,5-dimetiI-piridazin-3-il)-2-metil-3,4,5,6-tetrahidro-2H-[1,2']-bipirazinil-5'-il]-propan-2-ol.A pharmaceutical formulation of 2 - [(R) -4- (6-benzyl-4,5-dimetiI-pyridazin-3-yl) -2-methyl-3,4,5,6-tetrahydro-2H- [1, 2 '] - bipirazinyl-5'-yl] -propan-2-ol.

ARP110101288A 2010-04-16 2011-04-14 FORMULATIONS OF A PIRIDAZIN-BIPIRAZINIL AR080908A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32498010P 2010-04-16 2010-04-16
US36104010P 2010-07-02 2010-07-02

Publications (1)

Publication Number Publication Date
AR080908A1 true AR080908A1 (en) 2012-05-16

Family

ID=44170469

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101288A AR080908A1 (en) 2010-04-16 2011-04-14 FORMULATIONS OF A PIRIDAZIN-BIPIRAZINIL

Country Status (3)

Country Link
AR (1) AR080908A1 (en)
TW (1) TW201202223A (en)
WO (1) WO2011130500A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
WO2000071098A1 (en) * 1999-05-24 2000-11-30 Purepac Pharmaceutical Co. A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same
US7601715B2 (en) * 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors

Also Published As

Publication number Publication date
TW201202223A (en) 2012-01-16
WO2011130500A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
EA201290982A1 (en) PHARMACEUTICAL COMPOSITIONS, PREVENTING ABUSE
EA201201263A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DAGIGATRAN ETEXYLATE
EP2569330A4 (en) CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF
EA201101116A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
TN2012000392A1 (en) Oral formulations and lipophilic salts of methylnaltrexone
EA021377B9 (en) Modulators of toll-like receptors
MX2012001974A (en) Biaryl compounds and methods of use thereof.
EA201101118A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
DK2328601T3 (en) Linaclotide-containing formulations for oral administration
EP2906202A4 (en) DRUG FORMULATIONS FOR ORAL ADMINISTRATION
EA201100358A1 (en) DABIGATRAN FOR INTERTEGUAL SURGICAL CATHETERIZATION OF THE HEART
MX2009011165A (en) Pharmaceutical formulations containing lipoic acid derivatives.
EP2381773A4 (en) COMPOSITIONS FOR DRUG DELIVERY
EA201201202A1 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANE EXTILE
IN2015DN00885A (en)
MX2012007507A (en) Heteroaryl compounds and uses thereof.
EA201590805A1 (en) COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
IN2015DN00845A (en)
EA201170512A1 (en) COMPOSITION FOR ORAL ADMINISTRATION
AU2012280198A8 (en) Darunavir combination formulations
MX341976B (en) Darunavir formulations.
GEP201606595B (en) (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) –nifuratel
UY34295A (en) NEW N-HYDROXY ADMINISTRATION SCHEME -4- {2- [3- (N, NDIMETILAMINOMETIL) BENZOFURAN -2- ILCARBONILAMINO] ETOXI} BENZAMIDA
UY31128A1 (en) FORMULATION OF NEVIRAPINE OF PROLONGED RELEASE

Legal Events

Date Code Title Description
FB Suspension of granting procedure